Payman Zamani

Cardiology

3400 Civic Center Boulevard
East Pavilion, 2nd Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Calcium Channel Blockade Versus β-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial.

Calcium Channel Blockade Versus β-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: May 15, 2026

Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure.

Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure.

Journal: Circulation. Heart failure

Published: January 28, 2026

Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.

Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.

Journal: The Lancet. Neurology

Published: January 12, 2026

Proteome-Wide Genetic Investigation of Kidney Function in Heart Failure With Preserved Ejection Fraction.

Proteome-Wide Genetic Investigation of Kidney Function in Heart Failure With Preserved Ejection Fraction.

Journal: JACC. Heart failure

Published: August 07, 2025

Musclin Counteracts Skeletal Muscle Dysfunction and Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.

Musclin Counteracts Skeletal Muscle Dysfunction and Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.

Journal: Circulation. Heart failure

Published: May 13, 2025

Crossover Trial of Exogenous Ketones on Cardiometabolic Endpoints in Heart Failure With Preserved Ejection Fraction.

Crossover Trial of Exogenous Ketones on Cardiometabolic Endpoints in Heart Failure With Preserved Ejection Fraction.

Journal: JACC. Heart failure

Published: February 15, 2025

The Physiology Of the WEight Reduced State (POWERS) study: strategies for the analysis of biological specimens.

The Physiology Of the WEight Reduced State (POWERS) study: strategies for the analysis of biological specimens.

Journal: International journal of obesity (2005)

Published: February 06, 2025

Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic Associations.

Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic Associations.

Journal: Circulation. Heart failure

Published: January 20, 2025

Potassium Nitrate in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.

Potassium Nitrate in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.

Journal: JAMA cardiology

Published: December 18, 2024

Prognostic Significance and Biologic Associations of Senescence-Associated Secretory Phenotype Biomarkers in Heart Failure.

Prognostic Significance and Biologic Associations of Senescence-Associated Secretory Phenotype Biomarkers in Heart Failure.

Journal: Journal of the American Heart Association

Published: August 29, 2024

Metabolic and Pharmacokinetic Profiling of a Ketone Ester by Background SGLT2 Inhibitor Therapy in HFrEF.

Metabolic and Pharmacokinetic Profiling of a Ketone Ester by Background SGLT2 Inhibitor Therapy in HFrEF.

Journal: JACC. Basic to translational science

Published: July 31, 2024

Urinary Proteomics and Outcomes in Heart Failure With Preserved Ejection Fraction.

Urinary Proteomics and Outcomes in Heart Failure With Preserved Ejection Fraction.

Journal: Journal of the American Heart Association

Published: April 19, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026